Literature DB >> 9632782

The Mdm2 oncoprotein interacts with the cell fate regulator Numb.

T Juven-Gershon1, O Shifman, T Unger, A Elkeles, Y Haupt, M Oren.   

Abstract

The Mdm2 oncoprotein is a well-known inhibitor of the p53 tumor suppressor, but it may also possess p53-independent activities. In search of such p53-independent activities, the yeast two-hybrid screen was employed to identify Mdm2-binding proteins. We report that in vitro and in transfected cells, Mdm2 can associate with Numb, a protein involved in the determination of cell fate. This association causes translocation of overexpressed Numb into the nucleus and leads to a reduction in overall cellular Numb levels. Through its interaction with Numb, Mdm2 may influence processes such as differentiation and survival. This could potentially contribute to the altered properties of tumor cells which overexpress Mdm2.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9632782      PMCID: PMC108982          DOI: 10.1128/MCB.18.7.3974

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  68 in total

1.  Asymmetric segregation of Numb and Prospero during cell division.

Authors:  J A Knoblich; L Y Jan; Y N Jan
Journal:  Nature       Date:  1995-10-19       Impact factor: 49.962

2.  mdm-2 inhibits the G1 arrest and apoptosis functions of the p53 tumor suppressor protein.

Authors:  J Chen; X Wu; J Lin; A J Levine
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

3.  Control of daughter cell fates during asymmetric division: interaction of Numb and Notch.

Authors:  M Guo; L Y Jan; Y N Jan
Journal:  Neuron       Date:  1996-07       Impact factor: 17.173

4.  Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53.

Authors:  R Montes de Oca Luna; D S Wagner; G Lozano
Journal:  Nature       Date:  1995-11-09       Impact factor: 49.962

5.  Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53.

Authors:  S N Jones; A E Roe; L A Donehower; A Bradley
Journal:  Nature       Date:  1995-11-09       Impact factor: 49.962

6.  The phosphotyrosine interaction domain of SHC recognizes tyrosine-phosphorylated NPXY motif.

Authors:  Z Songyang; B Margolis; M Chaudhuri; S E Shoelson; L C Cantley
Journal:  J Biol Chem       Date:  1995-06-23       Impact factor: 5.157

7.  MDM2 transformation in the absence of p53 and abrogation of the p107 G1 cell-cycle arrest.

Authors:  M C Dubs-Poterszman; B Tocque; B Wasylyk
Journal:  Oncogene       Date:  1995-12-07       Impact factor: 9.867

8.  A functional p53-responsive intronic promoter is contained within the human mdm2 gene.

Authors:  A Zauberman; D Flusberg; Y Haupt; Y Barak; M Oren
Journal:  Nucleic Acids Res       Date:  1995-07-25       Impact factor: 16.971

9.  Cell type-specific inhibition of p53-mediated apoptosis by mdm2.

Authors:  Y Haupt; Y Barak; M Oren
Journal:  EMBO J       Date:  1996-04-01       Impact factor: 11.598

10.  Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease.

Authors:  R Sherrington; E I Rogaev; Y Liang; E A Rogaeva; G Levesque; M Ikeda; H Chi; C Lin; G Li; K Holman; T Tsuda; L Mar; J F Foncin; A C Bruni; M P Montesi; S Sorbi; I Rainero; L Pinessi; L Nee; I Chumakov; D Pollen; A Brookes; P Sanseau; R J Polinsky; W Wasco; H A Da Silva; J L Haines; M A Perkicak-Vance; R E Tanzi; A D Roses; P E Fraser; J M Rommens; P H St George-Hyslop
Journal:  Nature       Date:  1995-06-29       Impact factor: 49.962

View more
  47 in total

Review 1.  Mdm2: the ups and downs.

Authors:  T Juven-Gershon; M Oren
Journal:  Mol Med       Date:  1999-02       Impact factor: 6.354

2.  LNX functions as a RING type E3 ubiquitin ligase that targets the cell fate determinant Numb for ubiquitin-dependent degradation.

Authors:  Jing Nie; Melanie A McGill; Matt Dermer; Sascha E Dho; Cheryl D Wolting; C Jane McGlade
Journal:  EMBO J       Date:  2002-01-15       Impact factor: 11.598

3.  Siah-1 binds and regulates the function of Numb.

Authors:  L Susini; B J Passer; N Amzallag-Elbaz; T Juven-Gershon; S Prieur; N Privat; M Tuynder; M C Gendron; A Israël; R Amson; M Oren; A Telerman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

4.  MDM2 interacts with the C-terminus of the catalytic subunit of DNA polymerase epsilon.

Authors:  N Vlatkovic; S Guerrera; Y Li; S Linn; D S Haines; M T Boyd
Journal:  Nucleic Acids Res       Date:  2000-09-15       Impact factor: 16.971

5.  Numb expression and asymmetric versus symmetric cell division in distal embryonic lung epithelium.

Authors:  Ahmed H K El-Hashash; David Warburton
Journal:  J Histochem Cytochem       Date:  2012-06-19       Impact factor: 2.479

6.  Numb regulates stability and localization of the mitotic kinase PLK1 and is required for transit through mitosis.

Authors:  Travis L Schmit; Minakshi Nihal; Mary Ndiaye; Vijayasaradhi Setaluri; Vladimir S Spiegelman; Nihal Ahmad
Journal:  Cancer Res       Date:  2012-05-16       Impact factor: 12.701

7.  Inhibition of protein synthesis alters protein degradation through activation of protein kinase B (AKT).

Authors:  Chun-Ling Dai; Jianhua Shi; Yanxing Chen; Khalid Iqbal; Fei Liu; Cheng-Xin Gong
Journal:  J Biol Chem       Date:  2013-07-10       Impact factor: 5.157

Review 8.  Endocytic proteins in the regulation of nuclear signaling, transcription and tumorigenesis.

Authors:  Beata Pyrzynska; Iwona Pilecka; Marta Miaczynska
Journal:  Mol Oncol       Date:  2009-06-11       Impact factor: 6.603

9.  MDM2 regulates dihydrofolate reductase activity through monoubiquitination.

Authors:  Maria Maguire; Paul C Nield; Timothy Devling; Rosalind E Jenkins; B Kevin Park; Radoslaw Polański; Nikolina Vlatković; Mark T Boyd
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

Review 10.  MdmX regulates transformation and chromosomal stability in p53-deficient cells.

Authors:  Zdenka Matijasevic; Anna Krzywicka-Racka; Greenfield Sluder; Stephen N Jones
Journal:  Cell Cycle       Date:  2008-10-15       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.